Objective: To evaluate the effects of systemic leukocyte depletion by leukapheresis in an equine model of SIRS.
Results: All developed intestinal hypermotility, diarrhea and congested mucous membranes starting 12 hours after induction. At 24 hours, clinical signs of SIRS (tachycardia, hyperthermia and leukocytosis) and MODS (increased blood concentrations of glucose, creatinine and liver enzymes) were seen only in the untreated group. At 36 hours, all horses from the untreated group presented signs of SIRS and were euthanized. All mares from the treated group were alive at the end of the experimental period.
Conclusion:
The oligofructose model was efficient in producing SIRS and its complications in untreated horses. MODS and death related to SIRS were prevented by the use of this leukapheresis protocol. Our findings indicate that leukoapheris has the potential to be incorporated into the therapeutic arsenal against equine endotoxemia and sepsis. Objective: To verify the effects of leukapheresis by continuous flow on blood leukocyte counts in horses subjected to a SIRS model based on gastric administration of oligofructose.
Methods: In order to induce SIRS, oligofructose (10 g/kg) was given by nasogastric tube for six adult mares weighing 430 AE 35 kg. Twelve hours after administration, horses were sedated with detomidine and restrained in stocks. Both jugular veins were cannulated and connected to a Cobe Spectra apheresis machine in a dual-access continuous flow collection system. Leukocyte separation was achieved by centrifugation (765 RPM) using a separation factor of 500 and a withdrawal rate of 75 ml/min for a 4-hour period. Blood samples were obtained immediately before and 1, 2, 3 and 4 hours after leukapheresis procedure.
Results: No adverse effect was observed during the procedure. The mean (AE SD) volume of processed blood was 16628 ml (AE 275 ml) obtaining 682 ml (AE 40 ml) of plasma concentrated in leukocytes. Compared to the basal values, the mean circulating leukocyte counts had an 18.7% reduction in the first hour reaching a 23.9 reduction in the fourth hour. In differential counts similar reductions were observed at the end in all leukocyte types, such as segmented neutrophils (31%), monocytes (59%), lymphocytes (42.6%).
The leukapheresis protocol was successfully completed and was effective in reducing circulating inflammatory leukocytes in horses subjected to SIRS. Objective: To identify risk factors for acute ventral midline dehiscence and survival of cases after wire placement in wound revision.
Methods: A review of cases with dehiscence secondary to exploratory celiotomy presenting to a tertiary referral center between 2007 and 2017 was performed. Signalment, relaparotomy, incisional infection, time to deshiscence, incisional revision and outcome were recorded.
Results: 10 cases presented with acute dehiscence and visceral protrusion from the wound. Horses weighed between 227 and 900 kg, with a mean of 540 kg. Draft breeds (mean weight 549 kg) represented half of cases. 4/10 of cases dehisced after a second exploratory surgery. Dehiscence occurred an average of 8 days after celiotomy. 7/10 had signs of incisional infection prior to dehiscence. Two horses had hemoabdomen following difficult recoveries, with one necessitating blood transfusion. All cases had abdominal wall failure with the suture line remaining intact. Eight horses dehisced while still in hospital while neither horse who dehisced after discharge survived. Three horses had revision of the abdominal wall with 18 gauge wires, with 2/3 surviving.
Conclusions: Draft breeds, regardless of weight, and horses with incisional infections may be more predisposed to body wall failure and incisional dehiscence. Hemoabdomen may be a sentinel for abdominal wall failure and subsequent dehiscence. Survival of the patient after dehiscence depends on prompt identification of a failed incision and immediate re-laparotomy. Ethical animal research: none needed.
